Sygnomics
Serdar Turkarslan is a Senior Research Scientist at the Institute for Systems Biology since March 2009, having previously held positions as a Research Scientist and Postdoctoral Fellow in the same organization. Additionally, Serdar serves as Science Lead at Sygnomics since December 2020. Academic background includes a PhD in Cell and Molecular Biology from the University of Pennsylvania (2001-2007) and an MSc and Bachelor's degree in Biology from Orta Doğu Teknik Üniversitesi (1991-2001). During the graduate studies, Serdar also worked as a Teaching Assistant, including a year as Head TA overseeing a class of approximately 250 students. Earlier experience includes serving as a Computer and Network System Administrator at the Department of Biology, Middle East Technical University from 1998 to 2001.
This person is not in any teams
Sygnomics
SYGNOMICS aims to help clinicians improve patient outcomes at scale by accurately applying systems biology to cancer care. SYGNOMICS is developing an end-to-end solution that uses a unique and disruptive approach to enable personalized precision medicine for cancer patients. This solution will be powered by the Systems Genetics Network AnaLysis (SYGNAL) technology, which can accurately risk stratify a patient and personalize therapies (drugs and drug combinations) based on the unique characteristics of transcriptional “programs” underlying their disease.